Everything you need to know about GLP-1s for weight loss
Abstract
Glucagon-like peptide-1 (GLP-1) receptor agonists were touted as “breakthrough” drugs in 2023 — and their popularity has soared since. Around 2.5 million people each month accessed GLP-1s privately at the end of 2025, according to James Kingsland, chair of the Digital Clinical Excellence (DiCE) network of primary care digital health providers. Data also show that more than 400,000 items […]
Fields of Study & Subjects
Pharmacology and Obesity Treatment
Diabetes Treatment and Management
Bariatric Surgery and Outcomes
Publication details
- Journal / source
- Pharmaceutical journal/The pharmaceutical journal
- Publication date
- 1 January 2026